Legal & General Group’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.86K Sell
283
-61
-18% -$1.25K ﹤0.01% 3287
2025
Q4
$8.03K Hold
344
﹤0.01% 3289
2025
Q3
$10.9K Hold
344
﹤0.01% 3267
2025
Q2
$9.77K Sell
344
-115
-25% -$3.45K ﹤0.01% 3294
2025
Q1
$14.2K Hold
459
﹤0.01% 3065
2024
Q4
$15.2K Hold
459
﹤0.01% 3130
2024
Q3
$13.9K Hold
459
﹤0.01% 3182
2024
Q2
$13K Hold
459
﹤0.01% 3214
2024
Q1
$17K Hold
459
﹤0.01% 3028
2023
Q4
$18.9K Hold
459
﹤0.01% 3053
2023
Q3
$14.3K Hold
459
﹤0.01% 3164
2023
Q2
$18.4K Buy
+459
New +$18.8K ﹤0.01% 3137

Other funds holding SMTI

Legal & General Group's SMTI Position: Q1 2026 in Review

Legal & General Group reduced its Sanara MedTech (SMTI) stake by 18% in Q1 2026, selling an estimated $1.25K and leaving 283 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

Legal & General Group first reported a position in SMTI in Q2 2023 and has held it in 12 quarters since. The position peaked at $18.9K in Q4 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Legal & General Group held 283 shares of Sanara MedTech worth $4.86K as of Q1 2026.
  • Legal & General Group sold 61 Sanara MedTech shares in Q1 2026, an estimated $1.25K.
  • Sanara MedTech made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3287 holding.
  • Legal & General Group first reported a position in Sanara MedTech in Q2 2023 and has held it in 12 quarters since.
  • Legal & General Group's Sanara MedTech position peaked at $18.9K in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.